| |
Rwanda is a small, mountainous, densely populated nation located in central Africa. In the 1990s the country grabbed world headlines as a genocidal civil war between Rwanda's Hutu majority and Tutsi minority ethnic groups left over 900,000 people dead and another four million displaced. The country is currently rebuilding and returning to normalcy.
Though major causes of illness and death in Rwanda have been malaria, respiratory infections, and tuberculosis, AIDS is rapidly becoming the number one killer in the country. UNAIDS estimated at the end of 2001 that HIV/AIDS had infected 8.9 percent of adult Rwandans, and orphaned 260,000 children. The epidemic is expected to reduce Rwandan life expectancy to 32 years by 2010.
Before the political turmoil of the mid-1990s, the infection rate was much higher in urban areas than rural areas, where most of the population lived. But the civil war, by creating huge population movements and refugee camps, changed that pattern so that by 1997 the urban-rural gap in HIV prevalence was closing.
Sources: BBC country profile, Joint United Nations Programme on HIV/AIDS (UNAIDS), Synergy Project
|
|
|
| |
| Total population. mid-2009 |
9.9 (millions) |
| HIV prevalence 15-49, 2007/2008
|
2.8% |
| Tuberculosis death rate |
102/100,000 population |
| Prevalence of tuberculosis per 100,000 population, 2000 |
555 |
| Prevalence of tuberculosis per 100,000 population, 2004 |
660 |
| % Tuberculosis detection rate under DOTS, 2001 |
27 |
| % Tuberculosis detection rate under DOTS, 2004 |
30 |
| % Tuberculosis treatment success rate under DOTS, 2000 |
62 |
| % Tuberculosis treatment success rate under DOTS, 2003 |
68 |
| Malaria death rate (children under 5) |
1,049/100,000 population |
| GNI PPP Per Capita, 2008 |
101 (US$) |
| Life expectancy at birth |
48 years |
| Infant mortality rate |
62/1,000 live births |
| Total fertility rate |
5.5 per woman |
| Crude birth rate |
41/1,000 population |
| Crude death rate |
16/1,000 population |
| Adult male literacy level |
77% (pct. 15+ literate) |
| Adult female literacy level |
76% (pct. 15+ literate) |
| Contraceptive prevalence rate, modern methods |
27% of women in union |
| Estimated number of people living with HIV: Adults and Children, 2005 |
190,000 |
| Estimated number of people living with HIV: Adults and children, end 2003 |
250,000 |
| Estimated number of people living with HIV: Adults and children, end 2001 |
240,000 |
| Estimated number of people living with HIV: Adults (15+), 2005 |
160,000 |
| Estimated number of people living with HIV: Adults (15-49), end 2003 |
230,000 |
| Estimated number of people living with HIV: Adults (15-49), end 2001 |
220,000 |
| Estimated number of people living with HIV: Adults (15-49) rate (%), 2005 |
5.1% |
| Estimated number of people living with HIV: Adults (15-49) rate (%), 2003 |
5.1% |
| Estimated number of people living with HIV: Women (15+), 2005 |
91,000 |
| Estimated number of people living with HIV: Women 15-49, end 2003 |
130,000 |
| Estimated number of people living with HIV: Women 15-49, end 2001 |
120,000 |
| Estimated number of people living with HIV: Children (0-14), 2005 |
27,000 |
| Estimated number of people living with HIV: Children (0-14), end 2003 |
22,000 |
| Estimated number of people living with HIV: Children (0-14), end 2001 |
20,000 |
| Estimated number of AIDS deaths: Adults and children, 2005 |
21,000 |
| AIDS deaths in adults and children, end 2003
|
22,000 |
| AIDS deaths in adults and children, end 2001
|
21,000 |
| Estimated number of orphans due to AIDS: Children (0-17), 2005 |
210,000 |
| Orphans due to AIDS (0-17), living 2003
|
160,000 |
| Orphans due to AIDS (0-17), living 2001
|
160,000 |
| % Women (15-49), currently married or living with a partner, who have ever discussed AIDS prevention with their husband or partner |
66% |
Demographic data contained in this section was obtained from the following sources: The Population Reference Bureau’s 2009 World Population Data Sheet was used for total population, life expectancy at birth, infant mortality, fertility, birth rate, death rate, % of married women 15-49 using modern methods of contraception, % of population 15-49 with HIV/AIDS in 2007/2008, and the GNI PPP per capita (2008). Literacy rates were found in the Population Reference Bureau’s publication 2005 Women of Our World. HIV prevalence data for 2001 and 2003 was obtained from the UNAIDS Barcelona 2002 report; HIV prevalence and orphan data for 2005 was obtained from the UNAIDS Report on the Global AIDS Epidemic 2006. Data on the % women who have discussed AIDS prevention with their husband or partner can be found in ORC Macro and USAID’s Women’s Lives and Experiences: Changes in the Past Ten Years (Research Findings from the Demographic and Health Surveys). Childhood malaria mortality data was accessed in 2003 from the United Nations Statistics Divisions’ Millennium Indicators. Tuberculosis data was obtained from the United Nations Statistics Division’s Millennium Indicators: MDGInfo 2006. In some cases information was unavailable.
|
|
|
| |
|
|
|
|
|
|
| NIH |
Virologic Correlates of Heterosexual Transmission |
HIV/AIDS |
Epidemiology |
|
| |
(PI: Eric Hunter. 2002-2007.) A University of Alabama study to identify HIV-1 viruses transmitted between members of HIV-discordant heterosexual...
|
| NIH |
Couples HIV Counseling and Testing in Two African Capitals |
HIV/AIDS |
Prevention |
|
| |
(PI: Susan Allen. 2002-2007.) A research team based at the University of Alabama is implementing this voluntary counseling and testing program for...
|
| NIH |
Ethics Substudy Of An Anti-malarial Efficacy Study |
Malaria |
General |
|
| |
(PI GRADY, CHRISTINE P 2003) From project abstract: "This substudy seeks to inform deliberation and resolution of ethical issues related to...
|
| Other US |
USAID |
HIV/AIDS,Tuberculosis |
General |
|
| |
The USAID program in Rwanda, budgeted at $24.687 million in FY 2002, and with a proposed budget of $29.152 million for FY 2003, is focused on the...
|
| International |
A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel |
HIV/AIDS |
Drug Development |
Drug Development |
| |
International Partnership for Microbicides, Inc. (Study Director: Zeda Rosenberg; Rwanda PIs: Joseph Vyankandondera, Janneke van de Wijgert)...
|
| International |
An Expanded Safety Study of Dapivirine Gel 4759 in Africa |
HIV/AIDS |
Drug Development |
Prevention |
| |
International Partnership for Microbicides, Inc.(Study Director: Dr. Annalene Nel). 330 HIV-negative women between the ages of 18 and 40 will be...
|
| International |
An Expanded Safety Study of Dapivirine Gel 4789 in Africa |
HIV/AIDS |
Drug Development |
Prevention |
| |
International Partnership for Microbicides, Inc.(Study Director: Dr. Annalene Nel). 320 HIV-negative women between the ages of 18 and 40 will be...
|
| International |
International AIDS Vaccine Initiative (IAVI) |
HIV/AIDS |
Drug Development |
|
| |
In March 2003 IAVI is expanding human trials of a DNA-MVA vaccine, already in trials in Kenya, to include 45 subjects in Kigali, Rwanda. The vaccine...
|
| International |
Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children with Falciparum Malaria |
Malaria |
Drug Development |
|
| |
University Hosptial Ghent, with Centre Hospitalier De Butare. (PIs: Luc Van Bortel, Mark Twagirumukiza). This trial will test the effectiveness...
|
| International |
IPT of Malaria with SP in Different Zones of Drug Resistance in Rwanda |
Malaria |
Prevention |
|
| |
Institute of Tropical Medicine, Belgium (Study Director: Umberto D'Alessandro; PI: Daniel Ngamije). This study will examine the impact of an...
|
| International |
Luxembourg/ESTHER |
HIV/AIDS |
General |
|
| |
As part of the ESTHER initiative (also including Italy, France and Spain), Luxembourg has pledged $9.6 million (11 million euros) for two three-year...
|
| International |
Germany |
HIV/AIDS |
General |
|
| |
In May 2005 Rwanda and Germany signed a Memorandum of Understanding (MoU) worth eight million Euros (about $10.1 million) that will support good...
|
| International |
Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) |
HIV/AIDS,Tuberculosis,Malaria |
General |
|
| |
Rwanda has had several grant proposals approved by the GFATM. These include: - A Round 1 grant to improve the health system's response to HIV
...
|
| Foundation |
Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission |
HIV/AIDS |
Drug Development |
Prevention |
| |
(Study Chairs: Connie Celum, Jairam Lingappa, Anna Wald. Rwanda PI: Susan Allen) This study will enrol 3000 couples in Africa in which one...
|
| Foundation |
MTCT-Plus Initiative |
HIV/AIDS |
Prevention |
|
| |
The MTCT-Plus Initiative aims to prevent mother-to-child transmission of HIV in Rwanda and several other developing nations with high HIV/AIDS...
|
| Foundation |
Clinton Foundation HIV/AIDS Initiative |
HIV/AIDS |
General |
|
| |
The William J. Clinton Presidential Foundation has negotiated with pharmaceutical companies to obtain reduced prices for ARV drugs and HIV/AIDS...
|
|
|
|